Fulcrum Therapeutics, Inc. (FULC)
10.60
+0.46
(+4.54%)
USD |
NASDAQ |
Jan 20, 16:00
10.50
-0.10
(-0.94%)
Pre-Market: 09:05
Fulcrum Therapeutics Price: 10.60 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agios Pharmaceuticals, Inc. | 26.68 |
| Biogen, Inc. | 165.38 |
| CorMedix, Inc. | 6.88 |
| Apellis Pharmaceuticals, Inc. | 20.47 |
| NovaBay Pharmaceuticals, Inc. | 6.50 |
Price Related Metrics
| PEG Ratio | -0.032 |
| Price to Book Value | 2.892 |
| Earnings Yield | -11.12% |
| Market Cap | 573.66M |
| PEGY Ratio | -0.032 |